Effect of testosterone replacement associated with bariatric surgery in men with obesity

Not Applicable

Recruiting

• Conditions: Obesity; hypogonadism

• Registration Number: RBR-9qks3pc
• Lead Sponsor: Hospital e Maternidade São Domingos

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-13
• Last Update Posted: 26 July 2023
• Study Completion: 2024-09-30

Recruitment & Eligibility

• Status: Recruiting
• Sex: Male
• Target Recruitment: Not specified

Inclusion Criteria

Patients with Body Mass Index - BMI > 35; weighing up to 180 kg; with low testosterone levels (<350 ng/dl); classified as hypogonadal; who voluntarily agreed to participate in the research, in addition to understanding and consenting to participation through the TCLE (Free and Informed Consent Form)

Exclusion Criteria

Interest in fertility in the 6 months following therapy; diagnosis of active prostate or breast cancer; previous diagnosis of prostate cancer, with less than two years of curative treatment; previous diagnosis of breast cancer; severe voiding symptoms, translated through the IPSS score (International Prostatic Symptom Score) > 19; severe cardiopulmonary disease (eg unstable angina, recent myocardial infarction); personal or family history of thromboembolism; hematocrit above 48%; patients with implanted medical devices such as pacemakers or essential support devices such as monitors

Study & Design

• Study Type: Intervention
• Study Design: Not specified